<?xml version="1.0" encoding="UTF-8"?>
<ref id="B54-pharmaceuticals-13-00096">
 <label>54.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hamano</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Nishi</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Onose</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Okamoto</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Umegaki</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Yamazaki</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Hirota</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Ookura</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Takahashi</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Shingu</surname>
    <given-names>K.</given-names>
   </name>
  </person-group>
  <article-title>Efficacy of single-dose intravenous immunoglobulin administration for severe sepsis and septic shock</article-title>
  <source>J. Intensive Care</source>
  <year>2013</year>
  <volume>1</volume>
  <fpage>4</fpage>
  <pub-id pub-id-type="doi">10.1186/2052-0492-1-4</pub-id>
  <?supplied-pmid 25705399?>
  <pub-id pub-id-type="pmid">25705399</pub-id>
 </element-citation>
</ref>
